![](https://investorshub.advfn.com/uicon/434605.png?cb=1493182534)
Friday, October 20, 2017 12:24:25 PM
competitors in the QUETIAPINE FUMARATE ER(in this category I find the entire Mallinkrodt sales for Seroquel, so it is the subject of our interest):
in order - monthly sales - september
Accord (22.2Mln), Par (18.77Mln), Trupharma (8.57Mln), Mallinck (1.83Mln), AstraZeneca (440K), Lupin (302)
when I try to use the same filter for Focalin, I can find PAR sales, just under DEXMETHYLPHENIDATE HCL ER,
here we have in order - monthly sales - september
Sandoz 14.08Mln, Teva 12.22, Impax 7.59, Par 6.62, Mylan 4.01, Actavis 176K, repacker 0.9K
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM